We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Reunion Neuroscience Inc | NASDAQ:REUN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.12 | 1.18 | 1.07 | 0 | 01:00:00 |
Details of the presentations are as follows:
Podium Presentation Title: RE104 – A Novel, Shorter-Acting Psychedelic for Postpartum DepressionDate: Friday, April 12, 2024Time: 4:00-5:00 p.m. ETLocation: Westin Boston Seaport District: Harbor Ballroom I & II, Harbor LevelPresenter: Dr. Robert Alexander, Chief Medical Officer of Reunion
Poster PresentationTitle: RE104 – A Novel, Shorter-Acting Psychedelic for Postpartum DepressionSession Date: Saturday, April 13, 2024Session Time: 3:45-5:15 p.m. ETPoster #: S150Location: Westin Boston Seaport District: Grand Ballroom, Concourse Level
The poster will be available on Reunion’s website on Friday, April 12, 2024.
About Reunion Neuroscience Inc.
Reunion Neuroscience is committed to pushing the boundaries of neuroscience to develop innovative, patented, FDA-approved serotonergic psychedelic therapeutic solutions for postpartum depression (PPD) and other underserved mental health disorders. The Company’s lead asset, RE104, a proprietary, potential best-in-class, serotonergic psychedelic compound and the only 4-OH-DiPT prodrug in clinical development, is being evaluated as a potential treatment for postpartum depression, (NCT06342310), that could provide rapid symptom relief and durable efficacy. Reunion is actively investigating the use of RE104, which has a patent granted for exclusive rights for the composition of matter through 2042, in additional indications susceptible to being treated with a 5HT2A agonist molecule.
For more information about the company, visit https://reunionneuro.com.
Contact
Sarah Sutton, Argot Partners(518) 932-3680sarah@argotpartners.com
1 Year Reunion Neuroscience Chart |
1 Month Reunion Neuroscience Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions